<DOC>
	<DOCNO>NCT00546455</DOCNO>
	<brief_summary>Many metabolic complication obesity consequence abnormal response liver , muscle , fat insulin action . Fenretinide may improve effect insulin , prevent metabolic complication .</brief_summary>
	<brief_title>A Randomized , Double-blind Study Effects Fenretinide Administered Subjects With Obesity</brief_title>
	<detailed_description />
	<mesh_term>Obesity</mesh_term>
	<mesh_term>Insulin Resistance</mesh_term>
	<criteria>BMI &gt; 30 Diabetes Requiring Medication Poorly Controlled CoMorbidities</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2010</verification_date>
	<keyword>Obesity</keyword>
	<keyword>insulin resistance</keyword>
</DOC>